Nature Communications (Nov 2022)
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
Abstract
Enhancer of zeste homolog 2 (EZH2) has been associated with poor prognosis in triple negative breast cancer (TNBC). Here, the authors suggest a potential role for trimethylation function of EZH2 in driving peritoneal metastasis in TNBC.